← Eichor
Study identifier: NCT05992870 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Neoadjuvant Radiotherapy and Immediate Implant-Based Breast Reconstruction

Condition: Breast Cancer · Implant Breast Reconstruction · Neoadjuvant Radiotherapy  ·  Sponsor: Hubei Cancer Hospital

PhaseNA
Planned participants40
Who can joinFemale, 18 Years to 75 Years
Healthy volunteersNo

About this study

Neoadjuvant radiotherapy(NART) followed by mastectomy and immediate DIEP flap reconstruction is feasible and technically safe. However, reports of NACT followed immediate implant-based breast reconstruction are rare. Some studies have shown that NART followed immediate implant-based breast reconstruction seems feasible and can be safely attempted. It's well known that radiotherapy after implant-based breast reconstruction have negative effects on implant and cosmetic results. So, investigators conducted a polit study to learn about acute post-surgical complications following skin-sparing mastectomy and immediate implant-based breast reconstruction after NART.

This description comes directly from the study's public registry record.

Talk to the study team

Xinhong Wu, MD  ·  +8618602726300  ·  34053889@qq.com

Ning Zou, MD  ·  +8615007162698  ·  sunnyning116@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Xinhong WuWuhan, Hubei, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05992870